A negative correlation between the IC50 of entinostat and SALL4 expression level was observed, suggesting that lung cancer cells with high SALL4 expression were more sensitive to entinostat treatment (P = 0.03) (Figure 5b). Here, SALL4 is linked to lung carcinoma.